Ondine Biomedical (FRA:VF5) EPS (Diluted): €-0.05 (TTM As of Dec. 2024)

Ondine Biomedical  (FRA:VF5) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ondine Biomedical EPS (Diluted) Related Terms

The historical data trend for Ondine Biomedical's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical EPS (Diluted) Chart

Ondine Biomedical Annual Data
	Trend	Dec09	Dec10	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EPS (Diluted)		Get a 7-Day Free Trial					-0.05	-0.44	-0.07	-0.05	-0.05

Ondine Biomedical Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Diluted)	Get a 7-Day Free Trial															-0.04	-0.03	-0.02	-0.02	-0.03

FRA:VF5 vs VRTX, REGN, ALNY: EPS (Diluted) Comparison

For the Biotechnology subindustry, Ondine Biomedical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's PE Ratio distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's PE Ratio falls into.

Ondine Biomedical EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Ondine Biomedical's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as

Ondine Biomedical's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical Business Description